TRYP — Tryp Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- CA$5.79m
- CA$8.73m
Annual cashflow statement for Tryp Therapeutics, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.423 | -8.25 | -7.49 | -5.27 |
| Non-Cash Items | 0.211 | 3.56 | 0.578 | 0.66 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.175 | -0.365 | 1.11 | 0.986 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.036 | -5.06 | -5.81 | -3.62 |
| Capital Expenditures | -0.004 | -0.025 | -0.138 | -0.008 |
| Purchase / Acquisition of Intangibles | ||||
| Cash from Investing Activities | -0.004 | -0.025 | -0.138 | -0.008 |
| Financing Cash Flow Items | -0.014 | -0.68 | -0.04 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.06 | 7.76 | 4.14 | 2.15 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 1.02 | 2.67 | -1.81 | -1.48 |